DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted Lu-177-Radionuclide Tumor Therapy in Mice
Publication status
publishedExternal links
Journal / series
The Journal of Nuclear MedicineVolume
Pages / Article No.
Publisher
Society of Nuclear MedicineSubject
Albumin binder; Lu-177-cm09; Radionuclide therapy; Folate receptor; SPECTOrganisational unit
03688 - Schibli, Roger / Schibli, Roger
Notes
Published online 12 December 2012.More
Show all metadata
ETH Bibliography
yes
Altmetrics